ComplianceOnline

Mishaps in Pharmas – Causes and Clues

  • Date: March 31, 2010
  • Source: Admin
Webinar All Access Pass Subscription Abstract:

Pfizer is penalized for violating U.S. racketeering law. The drug giant now, has to pay a hefty amount of $142.1 million for promoting Neurontin for unapproved uses, illegally. In last few months, the world has witnessed many similar cases where the drug making companies are getting more and more involved with illegal or noncompliant means of producing drugs, which often bring these companies into limelight and brought down their reputation. This article highlights the pharma companies that have been under the spotlight for non-compliance so far this year.

Bookmark and Share

Trending Compliance Trainings

Trial Master File and Clinical Data Management Regulated by FDA
By - Carolyn Troiano
On Demand Access Anytime
Good Documentation Practice and Record Keeping Regulations (FDA & EMA)
By - Dr. Afsaneh Motamed Khorasani
On Demand Access Anytime
GAMP Data Integrity 21 CFR Part 11 Training Course
By - Kelly Thomas
On Demand Access Anytime
NEW Reclamation Process - Fed Gov't Payments
By - Donna K Olheiser
On Demand Access Anytime
Understanding and Preparing for FDA Pharmaceutical Inspections
By - Michael Ferrante
On Demand Access Anytime
How to conduct an effective BSA Audit
By - Justin Muscolino
On Demand Access Anytime
Installation and Qualification of the Packaging Lines
By - John E Lincoln
On Demand Access Anytime
Best Sellers
You Recently Viewed
    Loading